Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

185 projects found matching your search criteria :

  1. The role of glia cells in the mechanism of therapeutic action of ketogenic diet.

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Zuzanna Setkowicz

    Uniwersytet Jagielloński, Wydział Biologii

  2. Comprehensive analysis of the therapeutic potential of oligonucleotides for the treatment of polyglutamine diseases

    Call: SONATA 9 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Fiszer

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  3. Structural modifications of bacterial endotoxins (lipopolysaccharides) of significant importance to future antibacterial...

    Call: OPUS 8 , Panel: NZ6

    Principal investigator: dr hab. Jolanta Katarzyna Łukasiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  4. DNA repair pathways contributing to resistance to photodynamic therapy and as possible theraupeutic targets

    Call: OPUS 8 , Panel: NZ5

    Principal investigator: dr hab. Elżbieta Speina

    Instytut Biochemii i Biofizyki Polskiej Akademii Nauk

  5. The evaluation of influence of genes encoding oxytocin (OXT), dopamine (D) and arginine vasopressin (AVP) precursors pro...

    Call: OPUS 8 , Panel: HS6

    Principal investigator: dr hab. Katarzyna Kucharska

    Instytut Psychiatrii i Neurologii

  6. Evaluation of an influence of interaction between clopidogrel and statins possessing different pharmacokinetic propertie...

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: dr Marta Katarzyna Karaźniewicz-Łada

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  7. Evaluation of therapeutic efficacy of selected azaphenothiazines and studies on the mechanism of the immunosuppressive a...

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Michał Zimecki

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  8. Engineering of intelligent inhalable therapeutics with the capacity for guided accumulation and triggered release of act...

    Call: HARMONIA 6 , Panel: ST5

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

  9. Role of the complement system in tumorigenesis and therapeutic approaches.

    Call: SONATA BIS 4 , Panel: NZ6

    Principal investigator: dr hab. Marcin Okrój

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  10. Research on human eosinophils as a potential therapeutic target.

    Call: PRELUDIUM 7 , Panel: NZ7

    Principal investigator: Marek Rafał Grosicki

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  11. Analysis of relations on the level of metabolome, miRNome, and transcriptome of human renal cancer: towards identificati...

    Call: OPUS 7 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

    Centrum Medyczne Kształcenia Podyplomowego

  12. Cancer stem cells signaling pathways as a therapeutic terget in ovarian cancer chemotherapy

    Call: OPUS 7 , Panel: NZ5

    Principal investigator: prof. Maciej Zabel

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  13. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. GPR18 orphan receptor. Search for the tools to investigate GPR18 as potential therapeutic target

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: prof. Katarzyna Justyna Kieć-Kononowicz

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  15. Endogenous enkephalinase inhibitors and their novel synthetic analogs as potential new therapeutics for the treatment of...

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  16. Influence of AKT signaling pathway on CD20 expression and antitumor activity of therapeutic monoclonal antibodies.

    Call: OPUS 6 , Panel: NZ5

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  17. Motor thalamic nuclei as a potential therapeutic target for adenosine in parkinsonian and essential tremor; behavioural,...

    Call: OPUS 6 , Panel: NZ4

    Principal investigator: dr hab. Jadwiga Wardas

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. Project evaluation of diagnostic, treatment and costs in patients with heart failure among randomly selected outpatient ...

    Call: OPUS 1 , Panel: NZ7

    Principal investigator: prof. Tomasz Kazimierz Grodzicki

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

  19. Mass transport of therapeutic substance from the homogeneous or multi-phase implant which is its reservoir or formation ...

    Call: OPUS 6 , Panel: ST8

    Principal investigator: dr hab. Anna Trusek-Hołownia

    Politechnika Wrocławska, Wydział Chemiczny

  20. BCL11b - Potential Therapeutic Target in T cell Neoplasms

    Call: OPUS 5 , Panel: NZ1

    Principal investigator: dr hab. Grzegorz Przybylski

    Instytut Genetyki Człowieka Polskiej Akademii Nauk

  21. Infective endocarditis - the in vitro biomedical analysis of the potential therapeutic properties of selected phytochemi...

    Call: PRELUDIUM 5 , Panel: NZ6

    Principal investigator: Bartłomiej Micota

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  22. Innovative biopreparations with therapeutic activity - chemical and enzymatic methods for production of phospholipids co...

    Call: SONATA 5 , Panel: NZ9

    Principal investigator: dr Anna Gliszczyńska

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Nauk o Żywności

  23. The role of sphingosine-1-phosphate (S1P) receptors signaling in animal model of Parkinson disease. Searching of novel t...

    Call: PRELUDIUM 5 , Panel: NZ4

    Principal investigator: Joanna Agata Motyl

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  24. Regulation of Expression of Ecto-5'-Nucleotidase - Changes in Pathology and Therapeutic Potential

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Ryszard Tomasz Smoleński

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  25. Evaluation of peroxiredoxins 1 and 2 along with the thioredoxin-thioredoxin reductase system as new therapeutic targets ...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  26. Analysis of immungenecity and therapeutic activity of cell cancer vaccines based on cancer stem cells and induced plurip...

    Call: OPUS 4 , Panel: NZ6

    Principal investigator: prof. Andrzej Mackiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  27. Synthesis and analysis of potential furin inhibitors in the development of the new therapeutic strategies against viral ...

    Call: PRELUDIUM 4 , Panel: ST5

    Principal investigator: Monika Aleksandra Lewandowska-Goch

    Uniwersytet Gdański, Wydział Chemii

  28. Identification of potential therapeutic targets in melanoma stem-like cells

    Call: HARMONIA 3 , Panel: NZ2

    Principal investigator: prof. Małgorzata Ewa Czyż

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski z Oddziałem Stomatologicznym

  29. Identifcation of regulatory effects of bacteriophages with therapeutic potential on mammalian cell functions and immunit...

    Call: SONATA BIS 1 , Panel: NZ6

    Principal investigator: dr hab. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  30. Stimulation of endogenous neurogenesis as a novel therapeutic strategy in neonatal hypoxic-ischemic brain injury.

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: dr Małgorzata Nałęcz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  31. MicroRNA-dependent regulation of adhesion-related molecules in clear cell renal cell carcinoma: the search for markers o...

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

    Centrum Medyczne Kształcenia Podyplomowego

  32. Interactions between biologically active phytocompounds present in the fodder and selected therapeuticals used in the th...

    Call: SONATA 3 , Panel: NZ9

    Principal investigator: dr hab. Marta Mendel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  33. New reagents and methods in synthesis of modified nucleotides and their application for preparation biochemical tools an...

    Call: SONATA BIS 1 , Panel: ST5

    Principal investigator: dr hab. Jacek Jemielity

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  34. Ventilation, gas exchange and cardiac function in relation to intrapleural pressure changes in patients undergoing thera...

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: prof. Rafał Krenke

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  35. Searching for the molecular mechanisms of the therapeutic use of histamine signal and histamine receptors H1R, H2R and H...

    Call: HARMONIA 2 , Panel: NZ6

    Principal investigator: prof. Marek Michał Jutel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  36. PIM kinases as rational therapeutic targets in lymphoid malignancies.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr hab. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii

  37. Antibacterial molecules based on bacteriophage proteins and constant antibody fragments with therapeutic potential for t...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Karolina Aleksandra Filik-Matyjaszczyk

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  38. Modulating Neuroplasticity with Psilocybin: Assesment Therapeutic Potential in Treating Fentanyl use disorder

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Ewa Taracha

    Instytut Psychiatrii i Neurologii

  39. Identifying early biomarkers and molecular targets for therapeutic intervention in right ventricular dysfunction

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Przemysław Błyszczuk

    Uniwersytet Jagielloński

  40. Molecular insights into NAD+ metabolism in Huntington's disease: role in pathophysiology and preclinical assessment of t...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny

  41. Porous bioglass-alginate composite granules as the antibiotic delivery system with therapeutic and regenerative potentia...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Adrian Szewczyk

    Gdański Uniwersytet Medyczny

  42. A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure ...

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Marta Katarzyna Oknińska

    Centrum Medyczne Kształcenia Podyplomowego

  43. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  44. The H3K27M oncohistone-centred molecular mechanisms as therapeutic targets in pediatric malignant diffuse midline glioma...

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Katarzyna Leszczyńska

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  45. Improving the therapeutic potential of cytostatics through the use of abiotic metallacarboranes.

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Michalina Gos

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  46. Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi

  47. New phosphino derivatives of chinolone antibiotics and their complexes with copper (I) and copper (II) ions. Determinati...

    Call: OPUS 2 , Panel: ST5

    Principal investigator: prof. Małgorzata Janina Jeżowska-Bojczuk

    Uniwersytet Wrocławski, Wydział Chemii

  48. CD147 as a novel multifunctional modulator of podocyte metabolism and exosome biogenesis: Identification of new molecula...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: dr hab. Agnieszka Piwkowska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  49. ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease

    Call: WEAVE-UNISONO , Panel: NZ5

    Principal investigator: dr hab. Anna Haduch

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  50. Is there an escape from antibioticresistant ESKAPE pathogens present in wastewater - the importance of last-chance antib...

    Call: SONATA 19 , Panel: NZ9

    Principal investigator: dr Katarzyna Natalia Grudlewska-Buda

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy